- 7801. Anti-infectives affecting fetus or newborn via placenta or breast milk
- [ ] (UMLS (ICD9CM) C0158811) =Disease or Syndrome
| - 7851. antibody biosynthesis
- [The chemical reactions and pathways resulting in the formation of immunoglobulin. [GOC:add, ISBN:0781735149 "Fundamental Immunology"] ( GO )] (UMLS (CSP) C1753346) =Biologic Function
|
- 7802. Anti-MART-1 TCR Retroviral Vector-Transduced Autologous PBL
- [Human peripheral blood lymphocytes (PBL) isolated from a melanoma patient and were engineered to react with the melanoma antigen MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A). These PBLs are transfected with a retroviral vector encoding anti-MART-1 specific T-cell receptors, grown in culture, and then transferred back to the patient. These genetically modified PBL may recognize and halt the growth of MART-1-expressing melanoma cells. ( NCI )] (UMLS (NCI) C1510929) MSGV1AIB (Anti-MART-1 TCR) Retroviral Vector-Transduced Autologous PBL;
=Cell; ;
| - 7852. Antibody CC49, Monoclonal
- [A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. ( NCI )] (UMLS (NCI) C0281345) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 7803. Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL
- [Human tumor infiltrating lymphocytes (TIL) isolated from a melanoma patient and were engineered to react with the melanoma antigen MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A). These TILs are transfected with a retroviral vector encoding anti-MART-1 specific T-cell receptors, grown in culture, and then transferred back to the patient. These genetically modified TIL may recognize and halt the growth of MART-1-expressing melanoma cells. ( NCI )] (UMLS (NCI) C1510930) MSGV1AIB (Anti-MART-1 TCR) Retroviral Vector-Transduced Autologous TIL;
=Cell; ;
| - 7853. antibody conjugate
- [ ] (UMLS (CSP) C0598658) =Immunologic Factor; Indicator, Reagent, or Diagnostic Aid ;
|
- 7804. Anti-MUC-1
- [A monoclonal antibody recognizing human mucin, a cell surface antigen encoded by the MUC-1 gene. In normal tissue, mucin exists as heavily glycosylated form, while tumor-associated mucin molecules are underglycosylated. Underglycosylation exposes the normally cryptic tandem peptide repeats in cancer-associated mucin, thereby allows antigen-antibody interaction with MUC-1 antibody. As a result, the MUC-1 antibody inhibits the initiation of the immunosuppressive cascade triggered by mucin, including production and secretion of prostaglandin E2 (PGE2), followed by VEGF induction and suppression of natural killer cell, lymphokine-activated killer cell and cytotoxic T cell activity. ( NCI )] (UMLS (NCI) C1510931) Anti-MUC-1 Monoclonal Antibody;
=Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 7854. Antibody Conjugate Therapy
- (UMLS (NCI) C0280026) =Therapeutic or Preventive Procedure
|
- 7805. Anti-progesterones
- [A substance that blocks the activity of a progestin. ( NCI )] (UMLS (NCI) C1510932) Anti-Progestin;
Progesterone Antagonist =Pharmacologic Substance; ;
| - 7855. antibody deficiency syndrome
- [ ] (UMLS (CSP) C0003257) =Disease or Syndrome ;
|
- 7806. Anti-Rejection Therapy
- [deliberate suppression of immune system function for experimental or therapeutic purposes. ( CSP )] (UMLS (NCI) C0021079) =Therapeutic or Preventive Procedure ;
=immunologic technique;
Immunologically Directed Therapy =Desensitization;
blood cell depletion therapy;
radiation immunosuppression | - 7856. antibody dependent killer cell
- [similar to natural killer cells except cytotoxic action requires triggering by antibody coating of target cells, mediated by Fc receptors; may be derived from lymphocytes, polymorphs, eosinophils, or monocytes/macrophages. ( CSP )] (UMLS (CSP) C0596108) =Cell ;
=K cell;
|
- 7807. Anti-Tac
- [A monoclonal antibody that is being studied for treatment of adult T-cell leukemia. Also called dacliximab. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. ( NCI )] (UMLS (NCI) C0663182) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=IgG;
[IM600] IMMUNE SUPPRESSANTS;
Anti-Tac;
=Anti-Tac;
DACLIZUMAB 5 MG/ML | - 7857. antibody diversity
- [The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS. ( MSH )] (UMLS (CSP) C0003259) =Molecular Function ;
|
- 7808. Anti-Tac(Fv)-PE38
- [A toxic substance linked to an antibody that attaches to tumor cells and kills them. ( NCI )] (UMLS (NCI) C0655013) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 7858. antibody formation
- [synthesis of antibodies in response to B-cell activation by antigens; includes genetic regulation, recombination, all aspects of gene expression of the antibodies as well as the proliferation and differentiation of the B lymphocytes into plasma cells or memory cells. ( CSP )] (UMLS (CSP) C0003261) =Biologic Function ;
|
- 7809. Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide
- (UMLS (NCI) C0678056) =Therapeutic or Preventive Procedure ;
| - 7859. antibody hypersensitivity
- [ ] (UMLS (CSP) C0598650) =Pathologic Function
|
- 7810. Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide/Methylprednisolone
- (UMLS (NCI) C1327866) =Therapeutic or Preventive Procedure
| - 7860. antibody inhibitor
- [any substance or state which suppresses, prevents or opposes the actions of infection-fighting protein molecules in blood or secretory fluids known as antibodies. ( CSP )] (UMLS (CSP) C0178481) =Immunologic Factor =inhibitor/antagonist;
|
- 7811. Anti-Thymocyte Globulin/Busulfan/Melphalan
- (UMLS (NCI) C0678097) =Therapeutic or Preventive Procedure
| - 7861. antibody neutralization test
- [titration of an antiserum by testing a series of dilutions of virus or immune serum to a given end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). ( CSP )] (UMLS (CSP) C0027944) =Laboratory Procedure =serology/serodiagnosis;
|
- 7812. Anti-Thymocyte Globulin/Busulfan/Melphalan/Methylprednisolone
- (UMLS (NCI) C1327913) =Therapeutic or Preventive Procedure ;
| - 7862. antibody positive AIDS test
- [Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). ( MSH )] (UMLS (CSP) C0019699) =Finding ;
=HIV Infection;
|
- 7813. Anti-thymocyte Globulin/Cyclophosphamide
- (UMLS (NCI) C0677755) =Therapeutic or Preventive Procedure ;
| - 7863. Antibody Producing Cell
- [Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. (MeSH) ( NCI )] (UMLS (NCI) C0003273) =Cell ;
|
- 7814. Anti-thymocyte globulin/Cyclophosphamide/Cytarabine
- (UMLS (NCI) C1134543) =Therapeutic or Preventive Procedure
| - 7864. antibody receptor
- [family of cell surface molecules which mediate the specific intracellular effects of antibody binding, usually by the Fc region; do not confuse with other antibody-binding moieties which are normally antigens that bind to the Fab region. ( CSP )] (UMLS (CSP) C0034805) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =Receptor;
|
- 7815. Anti-Thymocyte Globulin/Cyclophosphamide/Fludarabine
- (UMLS (NCI) C0796377) ATG/CTX/FAMP =Therapeutic or Preventive Procedure ;
| - 7865. antibody specificity
- [property of antibodies which enables them to react with some antigenic determinants and not with others; specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. ( CSP )] (UMLS (CSP) C0003264) =Molecular Function ;
|
- 7816. Anti-thymocyte globulin/Cyclophosphamide/Fludarabine/methylprednisolone
- (UMLS (NCI) C1134567) =Therapeutic or Preventive Procedure
| - 7866. Antibody T-101, Monoclonal
- [A murine monoclonal antibody (MoAb) with application in Immunotherapy and radioimmunodetection in T-cell malignancies. MoAb T101 recognizes a 65kD glycoprotein, CD5 antigen, on the surface of T-cells. When radiolabeled, this MoAb has potential use in the radioimaging or may induce a cytotoxic T-cell response against CD5+ T cells. ( NCI )] (UMLS (NCI) C0280031) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 7817. Anti-thymocyte globulin/Cyclophosphamide/Methylprednisolone
- (UMLS (NCI) C0796690) =Therapeutic or Preventive Procedure ;
| - 7867. Antibody Therapy
- [Treatment with an antibody, a substance that can directly kill specific tumor cells or stimulate the immune system to kill tumor cells. ( NCI )] (UMLS (NCI) C0281176) =Therapeutic or Preventive Procedure ;
|
- 7818. Anti-thymocyte globulin/Cyclosporine
- (UMLS (NCI) C0879398) =Therapeutic or Preventive Procedure
| - 7868. antibody titering
- [determination of the concentration of an antibody relative to antigens in a sample by adding a standard solution to a test sample and calculating the composition from the end point. ( CSP )] (UMLS (CSP) C0474643) =Laboratory Procedure ;
=immunologic assay;
|
- 7819. Anti-thymocyte globulin/fludarabine/melphalan
- (UMLS (NCI) C0935760) =Therapeutic or Preventive Procedure
| - 7869. antibody treated bone marrow transplant
- (UMLS (NCI) C0279022) =Therapeutic or Preventive Procedure
|
- 7820. Anti-thymocyte Globulin/Melphalan
- (UMLS (NCI) C0393042) =Therapeutic or Preventive Procedure
| - 7870. Antibody-Mediated Lympholysis
- [The cytotoxicity of cells depending on antibody recognition. The killing of a target cell by a killer cell by means of an antibody directed to the target by the antigen-binding arms and anchored to the killer cell via an Fc receptor. ( NCI )] (UMLS (NCI) C0301895) =Cell Function ;
|
- 7821. Anti-thymocyte globulin/melphalan/methylprednisolone
- (UMLS (NCI) C0796691) =Therapeutic or Preventive Procedure ;
| - 7871. Anticachectic Therapy
- [Treatment to manage or alleviate the fatigue and weight loss often associated with cancer. ( NCI )] (UMLS (NCI) C0279840) =Therapeutic or Preventive Procedure
|
- 7822. Anti-Thymocyte Globulin/Methotrexate/Mycophenolate Mofetil/Tacrolimus
- (UMLS (NCI) C1327864) =Therapeutic or Preventive Procedure
| - 7872. Anticancer Drugs
- (UMLS (HL7) C1548818) =Health Care Activity =Consent Type;
|
- 7823. Anti-thymocyte globulin/Methylprednisolone
- (UMLS (NCI) C0796689) =Therapeutic or Preventive Procedure ;
| - 7873. Anticholinergic Agent
- [group of drugs that bind to but do not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists. ( CSP )] (UMLS (NCI) C0242896) =Pharmacologic Substance ;
=neuropharmacologic agent;
neurotransmitter antagonist =atropine;
PROMAZINE;
1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-,(-)-tropate(ester) |
- 7824. Anti-thymocyte globulin/methylprednisolone/tacrolimus
- (UMLS (NCI) C0879449) =Therapeutic or Preventive Procedure ;
| - 7874. Anticipatory Nausea and Vomiting
- (UMLS (NCI) C0279036) =Finding
|
- 7825. Anti-thymocyte globulin/thiotepa
- (UMLS (NCI) C0879289) =Therapeutic or Preventive Procedure
| - 7875. Anticipatory Vomiting
- [Vomiting caused by expectation of discomfort or unpleasantness. ( MSH )] (UMLS (NCI) C0042964) =Sign or Symptom =Braken;
|
- 7826. anti-TNF therapy
- (UMLS (NCI) C0281481) =Therapeutic or Preventive Procedure
| - 7876. Anticoagulation
- [Events or activities that prevent or inhibit coagulation. ( NCI )] (UMLS (NCI) C0003281) =Therapeutic or Preventive Procedure ;
|
- 7827. Anti-Transferrin MOAB E2.3
- [A murine IgG1 monoclonal antibody directed against the human transferrin (Tf) receptor. Monoclonal antibody E2.3 binds to the Tf receptor, blocking the binding of transferrin to the receptor and resulting in decreased tumor cell growth. (NCI04) ( NCI )] (UMLS (NCI) C0677773) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 7877. Anticoagulation Therapy
- (UMLS (NCI) C0741135) Anticoagulation Treatment =Therapeutic or Preventive Procedure ;
|
- 7828. Anti-VEGF
- [A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor. ( NCI )] (UMLS (NCI) C0796392) Anti-VEGF Humanized Monoclonal Antibody;
Anti-VEGF RhuMAb;
Bevacizumab;
BEVACIZUMAB UNIDENTIFIED;
MoAb VEGF;
Monoclonal Antibody Anti-VEGF;
Recombinant Humanized Anti-VEGF Monoclonal Antibody;
Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor;
RhuMAb VEGF;
rhuMabVEGF =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 7878. Anticode G3139
- (UMLS (NCI) C1144384) bcl-2 antisense oligodeoxynucleotide G3139;
BCL-2 Antisense/G3139;
G3139;
G3139 Antisense Oligonucleotide;
G3139 BCL-2 Antisense Oligo;
G3139 BCL-2 Antisense Oligodeoxynucleotide;
G3139 BCL-2 Antisense Oligonucleotide;
=Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 7829. antiAIDS agent
- [agents used to treat AIDS and/or stop the spread of the HIV infection; frequently used in a combination cocktail or mixture of therapeutics; for specific agents, SEE also ANTIVIRAL AGENT. ( CSP )] (UMLS (CSP) C0376565) =Pharmacologic Substance =[AM800] ANTIVIRALS;
| - 7879. Anticonvulsant Therapy
- (UMLS (NCI) C0521306) =Therapeutic or Preventive Procedure
|
- 7830. antialcoholic drug
- [ ] (UMLS (CSP) C0597780) =Pharmacologic Substance ;
| - 7880. Anticonvulsants affecting fetus or newborn via placenta or breast milk
- [ ] (UMLS (ICD9CM) C1561781) MAT ANTICONV AFF NB/FET;
=Pathologic Function |
- 7831. antiallergic agent
- [group of agents that are used to treat allergic reactions; most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. ( CSP )] (UMLS (CSP) C0282555) =Pharmacologic Substance ;
=Drug;
=[AH000] ANTIHISTAMINES;
bronchodilator;
[NT100] DECONGESTANTS, NASAL;
cromoglycic acid | - 7881. Anticonvulsants and anti-Parkinsonism drugs causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0481142) =Injury or Poisoning
|
- 7832. Antiandrogen Therapy
- [Treatment with drugs used to block production or interfere with the action of male sex hormones. ( NCI )] (UMLS (NCI) C0279492) =Therapeutic or Preventive Procedure
| - 7882. ANTIDEPRESS ABUSE-CONTIN
- [ ] (UMLS (ICD9CM) C0154541) =Mental or Behavioral Dysfunction
|
- 7833. antiantibody
- [antibody specific for another antibody. ( CSP )] (UMLS (CSP) C1624602) =Amino Acid, Peptide, or Protein; Immunologic Factor =Ab;
| - 7883. ANTIDEPRESS ABUSE-EPISOD
- [ ] (UMLS (ICD9CM) C0154542) =Mental or Behavioral Dysfunction
|
- 7834. antianxiety agent
- [A medicine used to treat anxiety or muscle spasms. ( NCI )] (UMLS (CSP) C0040616) =Pharmacologic Substance
| - 7884. ANTIDEPRESS ABUSE-REMISS
- [ ] (UMLS (ICD9CM) C0154543) =Mental or Behavioral Dysfunction
|
- 7835. antiarthritic agent
- [agent used to alleviate arthritis. ( CSP )] (UMLS (CSP) C0596107) =Pharmacologic Substance ;
=Drug;
=6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid;
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide | - 7885. ANTIDEPRESS ABUSE-UNSPEC
- [ ] (UMLS (ICD9CM) C0375185) =Mental or Behavioral Dysfunction
|
- 7836. antiatherogenic agent
- [biologically active substance that prevents atherogenesis, the accumulation of lipid containing plaques on the innermost layers of the arteries. ( CSP )] (UMLS (CSP) C0684286) =Pharmacologic Substance =[CV000] CARDIOVASCULAR MEDICATIONS;
| - 7886. Antidepressant type abuse
- [ ] (UMLS (ICD9CM) C0154540) =Mental or Behavioral Dysfunction
|
- 7837. Antibacterial Agent
- [substances produced by microorganisms or biomimetics that can inhibit or suppress the growth of other microorganisms; frequently used without reference to the microbial origins of the original substance. ( CSP )] (UMLS (NCI) C0003232) =Antibiotic ;
| - 7887. antidiabetic
- [By supplying insulin or stimulating endogenous insulin production, natural or synthetic Anti-diabetic Agents relieve diabetes, reducing and controlling blood sugar levels. Most current insulin products are obtained by recombinant DNA technology and mimic natural insulin. Oral hypoglycemic agents that stimulate pancreatic insulin production and increase glucose uptake in various tissues mainly belong to sulfonylurea and biguanide classes. (NCI04) ( NCI )] (UMLS (CSP) C0935929) Anti-diabetic Agent;
=Pharmacologic Substance |
- 7838. Antibacterial Agent
- [substance that destroys bacteria or prevents their growth or replication. ( CSP )] (UMLS (NCI) C0279516) =Antibiotic =antiinfective agent;
=aminacrine;
antitubercular agent;
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid;
4,4'-Sulfonylbis[benzenamine];
METRONIDAZOLE;
4-Aminobenzenesulfonamide;
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine | - 7888. Antidiabetic Hormone
- [pancreatic hormone secreted by the alpha cells of the pancreatic islets; a 29-amino acid straight chain polypeptide that plays an important role in regulation of blood glucose concentration, ketone metabolism, and several other biochemical and physiological processes. ( CSP )] (UMLS (NCI) C0017687) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone =neuropeptide;
pancreas hormone;
Peptides;
[HS503] ANTIHYPOGLYCEMICS =GLUCAGON 10 MG;
GLUCAGON 1 MG;
|
- 7839. antibacterial antibody
- [immunoglobulins induced by exposure to bacterial antigens. ( CSP )] (UMLS (CSP) C0003244) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 7889. Antidiabetic Hormone
- [The recombinant form of the endogenous polypeptide hormone Glucagon consisting of 29 amino acids responsible for the release of stored glucose, causing increased blood glucose levels. Clinical Use: Diagnostic Aid for Imaging Studies and Hypoglycemia. ( NCI )] (UMLS (NCI) C0876232) Glucagon;
glucagon (rDNA);
Hyperglycemic Glycogenolytic Factor;
Recombinant Glucagon =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone |
- 7840. Antibiotic (U-29,135)
- [A benzoquinone antineoplastic antibiotic isolated from the bacterium Streptomyces hygroscopicus. Geldanamycin binds to and inhibits the cytosolic chaperone functions of heat shock protein 90 (HSP90). HSP90 maintains the stability and functional shape of many oncogenic signaling proteins; the inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins that may be over-expressed or overactive in tumor cells. (NCI04) ( NCI )] (UMLS (NCI) C0061179) =Organic Chemical; Antibiotic ;
| - 7890. antidiuresis
- [ ] (UMLS (CSP) C0232826) =Disease or Syndrome
|
- 7841. Antibiotic BN 183B
- (UMLS (NCI) C0106750) =Organic Chemical; Antibiotic
| - 7891. antidiuretic
- [agent that suppresses urine formation. ( CSP )] (UMLS (CSP) C0596110) =Pharmacologic Substance ;
=Drug;
|
- 7842. Antibiotic FR 901228
- (UMLS (NCI) C0963679) FK228;
FR901228;
=Amino Acid, Peptide, or Protein; Antibiotic ;
| - 7892. antidiuretic hormone defective syndrome
- [A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS). ( MSH )] (UMLS (CSP) C0687720) =Disease or Syndrome ;
=diabetes insipidus;
|
- 7843. Antibiotic MA144-A1
- (UMLS (NCI) C0917820) MA144-A1;
=Organic Chemical; Pharmacologic Substance ;
| - 7893. Antidiuretic Hormone Receptor 1A
- [This protein acts as receptor for arginine vasopressin. This receptor belongs to the subfamily of G-protein coupled receptors which includes AVPR1B, V2R and OXT receptors. Its activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system. The receptor mediates cell contraction and proliferation, platelet aggregation, release of coagulation factor and glycogenolysis. ( NCI )] (UMLS (NCI) C0284725) =Amino Acid, Peptide, or Protein; Receptor
|
- 7844. Antibiotic No. 899
- (UMLS (NCI) C0949456) =Amino Acid, Peptide, or Protein; Antibiotic
| - 7894. Antidiuretic Hormone Receptor 1B
- [This protein acts as receptor for arginine vasopressin. This receptor belongs to the subfamily of G-protein coupled receptors which includes AVPR1A, V2R and OXT receptors. Its activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system. The receptor is primarily located in the anterior pituitary, where it stimulates ACTH release. It is expressed at high levels in ACTH-secreting pituitary adenomas as well as in bronchial carcinoids responsible for the ectopic ACTH syndrome. A spliced antisense transcript of this gene has been reported but its function is not known. ( NCI )] (UMLS (NCI) C0284726) =Amino Acid, Peptide, or Protein; Receptor
|
- 7845. Antibiotic Prophylaxis
- [Administration of antibiotics with the intent of preventing bacterial infection, frequently in persons with prosthetic heart valves, joints, etc. ( NCI )] (UMLS (NCI) C0282638) =Therapeutic or Preventive Procedure ;
| - 7895. antiDNA autoantibody
- [autoimmune, pathological antibodies against histones, DNA, nuclear RNA, or other components of the cell nucleus. ( CSP )] (UMLS (CSP) C0003243) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 7846. antibiotic resistance
- [The mechanisms, functions, activities, or processes exhibited by microorganisms, especially bacteria, to resist or to become tolerant to antibiotics. ( NCI )] (UMLS (CSP) C0949285) =Organism Attribute
| - 7896. antidote
- [agent counteracting or neutralizing the action of a poison. ( CSP )] (UMLS (CSP) C0003295) =Pharmacologic Substance ;
|
- 7847. Antibiotic sensitivity, disk
- [Susceptibility, Antibiotic sensitivity, disk ( HL7V3.0 )] (UMLS (HL7) C1283010) =Laboratory Procedure =Susceptibility Testing;
| - 7897. antidromic impulse
- [neural impulse conducted in the opposite direction to normal. ( CSP )] (UMLS (CSP) C0178482) =Organ or Tissue Function =neural conduction;
|
- 7848. Antibiotic Therapy
- [Treat bacterial infections with antibiotics ( NCI )] (UMLS (NCI) C0338237) =Therapeutic or Preventive Procedure
| - 7898. antiemetic support
- (UMLS (NCI) C0279035) =Therapeutic or Preventive Procedure
|
- 7849. Antibiotics, reaction to
- (UMLS (NCI) C0850100) Reaction to Antibiotics;
=Finding | - 7899. antiepileptic
- [ ] (UMLS (CSP) C0003299) =Pharmacologic Substance ;
|
- 7850. Antibody Binding Site
- [Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of FAB FRAGMENTS. ( MSH )] (UMLS (NCI) C0005457) =Immunologic Factor ;
| - 7900. Antiestrogen
- [A substance that blocks the activity of estrogens, the family of hormones that promote the development and maintenance of female sex characteristics. ( NCI )] (UMLS (NCI) C0014930) =Pharmacologic Substance =hormone antagonist;
=1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene;
[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone |
home 
Armenian-English 
top